Compare Definium Therapeutics Inc. Common Shares (DFTX) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs ProShares Ultra Gold ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while ProShares Ultra Gold ETF trades at $46.36 (market cap $715.43M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 6.6× ProShares Ultra Gold ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, ProShares Ultra Gold ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and ProShares Ultra Gold ETF for 23 Days on average.
| DFTX | UGL | |
|---|---|---|
Market Cap | $4.71B | $715.43M |
Volume | 1,966,636 | 3,002,043 |
Sector | Health | Leveraged / Inverse |
52-Week High | $48.45 | $85.62 |
52-Week Low | $10.68 | $42.79 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $3.67B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
UGL stock is trading at $44.43, down 3.29% over the past day amid a broader bearish technical signal. The stock faces selling pressure with moving averages and oscillators indicating a downtrend, while key support lies at $43. Recent news highlights gold's volatility driven by shifting Federal Reserve rate expectations and Treasury yield movements, impacting sentiment.
The outlook remains cautious with technical indicators signaling bearish momentum, though oversold conditions on the 12-day RSI may offer short-term relief. Risks include persistent macroeconomic headwinds from interest rates and dollar strength, while the lack of available fundamental data limits visibility on the company's financial health and valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
